Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹141 Cr
Revenue (TTM)
₹83 Cr
Net Profit (TTM)
₹10 Cr
ROE
46.2 %
ROCE
57.5 %
P/E Ratio
10.4
P/B Ratio
4.2
Industry P/E
39.7
EV/EBITDA
7.2
Div. Yield
0 %
Debt to Equity
0.2
Book Value
₹24
EPS
₹8.5
Face value
10
Shares outstanding
16,387,200
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
---|---|---|---|---|---|---|---|
Quest Laboratories
| -29.1 | -19.7 | -16.1 | -42.5 | -- | -- | -- |
BSE Healthcare
| -5.4 | 0.7 | 5.6 | 15.1 | 26.7 | 21.5 | 10.3 |
BSE Small Cap
| -4.9 | 2.1 | 15.7 | 0.8 | 29.2 | 33.9 | 16.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
---|---|---|---|---|---|---|---|---|
Quest Laboratories
|
85.8 | 140.6 | 82.6 | 10.1 | -- | 46.2 | 10.4 | 4.2 |
842.5 | 7,621.0 | 2,115.1 | 272.4 | 17.8 | 14.2 | 28 | 3.8 | |
1,091.4 | 8,921.7 | 1,006.9 | 160.4 | 20.4 | 12.6 | 56.2 | 6.8 | |
541.1 | 8,504.0 | 4,118.2 | 343.8 | 7.6 | 10.7 | 25.1 | 2.8 | |
359.8 | 4,436.4 | 1,859.8 | 90.8 | 10.4 | 7.4 | 48.9 | 3.5 | |
836.0 | 4,784.9 | 1,243.7 | 128.3 | 13.0 | 13.8 | 37.3 | 5.0 | |
999.0 | 2,466.6 | 356.3 | 100.9 | 25.0 | 13.3 | 24.4 | 3.1 | |
53.3 | 2,036.7 | 488.2 | 70.5 | 17.2 | 13 | 29.3 | 3.4 | |
150.6 | 4,885.7 | 71.8 | -342.5 | -467.5 | -- | -- | -22.5 | |
926.5 | 2,757.7 | 293.0 | -56.7 | -16.7 | -29.5 | -- | 12.3 |
No Review & Analysis are available.
--
Incorporated
1998
Chairman
--
Managing Director
Anil Kumar Sabarwal
Headquarters
Dhar, Madhya Pradesh
Website
Looking for more details about Quest Laboratories Ltd’s IPO? Explore our IPO Details page.
The total asset value of Quest Laboratories Ltd stood at ₹ 59 Cr as on 31-Mar-24
The share price of Quest Laboratories Ltd is ₹85.80 (NSE) as of 19-Jun-2025 IST. Quest Laboratories Ltd has given a return of -42.47% in the last 1 years.
Quest Laboratories Ltd has a market capitalisation of ₹ 141 Cr as on 19-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Quest Laboratories Ltd is 4.25 times as on 19-Jun-2025, a 14% premium to its peers’ median range of 3.72 times.
The P/E ratio of Quest Laboratories Ltd is 10.37 times as on 19-Jun-2025, a 74% discount to its peers’ median range of 39.70 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Quest Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Quest Laboratories Ltd.
The prominent promoters of Quest Laboratories Ltd are
Name of promoters | Holding percentage |
---|---|
ANIL KUMAR SABARWAL |
62.29%
|
TEJASWINI SABARWAL |
2.55%
|
VINAYAK SABARWAL |
1.37%
|
The chairman of the company is , and the managing director is Anil Kumar Sabarwal.
There is no promoter pledging in Quest Laboratories Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
9,040
|
|
8,990
|
|
8,026
|
|
5,384
|
|
5,202
|
|
4,635
|
|
2,868
|
|
2,488
|
|
2,233
|
Quest Laboratories Ltd | Ratios |
---|---|
Return on equity(%)
|
46.15
|
Operating margin(%)
|
18.14
|
Net Margin(%)
|
12.19
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Quest Laboratories Ltd was ₹10 Cr.